PRESS RELEASE 30 MAY 2023 New clinical data on Vuse illustrates beneficial public health impact of Tobacco Harm Reduction Major study shows adult consumers using BATs vapour brand Vuse i demonstrated significantly better results for biomarkers relevant to smoking-related diseases than smokers Lower levels of cigarette smoke toxicants classified as harmful or potentially harmful ii found in participants using Vuse exclusively compared to smokers Study adds to the scientific evidence around vaping as a reduced-risk * products category and highlights the value of Vuse in Tobacco Harm Reduction Results underscore vaping products contribution to Tobacco Harm Reduction and reinforce BATs commitment to building A Better Tomorrow by reducing the health impact of its business New results from one of the largest ever vapour product studies, which analysed BATs flagship vapour brand Vuse, have been published in the journal of Internal and Emergency Medicine

As summarized in the complaint, USPS first decreed that the evaluation of suspicious senders must be made only by specially designated personnel, but never actually provided such personnel
It does not own all these brands but is licensed by other companies to distribute them
It's straightforward, affordable, and familiar to many long-time vapers
28,29 Exceptions were made for research about topics for which randomization at the patient level was not possiblesuch as systems interventions, which often randomized clinics or providers